KYTX

KYVERNA THERAPEUTICS INC

KYTX·501976104·US·Common Stock·Healthcare - Biotechnology-13D/G

KYTX (KYVERNA THERAPEUTICS INC) is held by 72 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($27.9M), VANGUARD CAPITAL MANAGEMENT LLC ($16.9M), GEODE CAPITAL MANAGEMENT, LLC ($9.4M). Net institutional sentiment: Mixed.

72
Holders
(3 Elite)
$145.5M
Total Value
58% (74)
Consensus
43 buying - 31 selling
13F: Insider & Congress: Updated regularly
KYTX

Smart Money Verdict

View all
Loading verdict
Held by 72 funds
3 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Dec 22, 2025 · Activists Aug 14, 2026 · Congress none

ActivistBLBain Capital Life Sciences Opportunities III, LP4.8%Aug 14, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.1%Jul 29, 2026
ActivistBLBain Capital Life Sciences Opportunities III, LP5.4%Feb 17, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.1M(+257.4%)$27.9M0.0%+7.45%
46
Increased
1.9M(+6.4%)$16.9M0.0%+6.65%
30
Increased
1M(+147.6%)$9.4M0.0%-9.01%
45
Increased
982,307(+0.5%)$8.8M0.0%+0.05%
28
Increased
982,233(+610.2%)$8.8M0.0%-3.19%
44
Unchanged
845,325$7.5M0.0%+3.33%
0
Decreased
639,780(-36.4%)$5.7M0.0%-2.97%
0
Unchanged
500,000$4.5M0.0%-7.91%
0
Decreased
469,346(-35.0%)$4.2M0.0%-4.07%
0
Increased
373,009(+226.1%)$3.3M0.0%-1.62%
43
Decreased
365,574(-18.7%)$3.3M0.0%+21.12%
0
Increased
335,230(+57.5%)$3M0.0%+5.92%
38
Decreased
333,899(-9.1%)$3M0.0%+43.04%
0
Increased
319,666(+51.4%)$2.8M0.0%-22.18%
37
Increased
315,354(+304.1%)$2.8M0.0%-0.41%
42
Decreased
310,632(-24.6%)$2.8M0.0%+0.85%
0
New
282,189$2.5M0.0%-3.37%
36
Increased
265,405(+376.3%)$2.4M0.0%+3.00%
42
Increased
259,667(+15.6%)$2.3M0.0%+5.77%
30
Increased
245,587(+543.0%)$2.2M0.0%-1.84%
42

Showing 1-20 of 82

1 / 5
KYTXKYTXKYVERNA THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used